|
AVE9633
|
DB06318 |
[AVE9633 is an anti-CD33 monoclonal antibody-DM4 conjugate.] |
|
Elotuzumab
|
DB06317 |
[Elotuzumab is a humanized IgG1 (Immunoglobulin G) monoclonal antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies. Elotuzumab targets SLAMF7, also known as Signaling Lymphocytic Activation Molecule Family member 7, a cell surface glycoprotein. Elotuzumab consists of the complementary determining regions (CDR) of the mouse antibody, MuLuc63, grafted onto human IgG1 heavy and kappa light chain frameworks. Elotuzumab is produced in NS0 cells by recombinant DNA technology. Elotuzumab has a theoretical mass of 148.1 kDa for the intact antibody. Elotuzumab was approved on November 30, 2015 by the U.S. Food and Drug Administration. Elotuzumab is marketed under the brand Empliciti™ by Bristol-Myers Squibb.] |
|
Fluprednidene
|
DB08970 |
[Fluprednidene is a corticosteroid.] |
|
SGX-523
|
DB06314 |
[A MET receptor tyrosine kinase inhibitor.] |
|
2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
|
DB07640 |
|
|
Fluocortolone
|
DB08971 |
[Fluocortolone is a glucocorticoid with anti-inflammatory activity used topically for various skin disorders.] |
|
BNC105
|
DB06313 |
|
|
Flumequine
|
DB08972 |
[Flumequine is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class used to treat bacterial infections.] |
|
Decyl(dimethyl)phosphine oxide
|
DB07641 |
|
|
Fluclorolone acetonide
|
DB08973 |
[Fluclorolone acetonide (INN) or flucloronide (USAN) is a topical corticosteroid. It is marketed under the brand names Cutanit and Topicon.] |
|
5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine
|
DB07642 |
|
|
Carotuximab
|
DB06322 |
|
|
Etilefrine
|
DB08985 |
[Etilefrine is an adrenergic agonist that appears to interact with beta-2 and some alpha adrenergic receptors. It has been used as a vasoconstrictor agent.] |
|
(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC
|
DB07654 |
|
|
R-348
|
DB06321 |
|
|
3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE
|
DB07655 |
|
|
Etifoxine
|
DB08986 |
[Etifoxine is an anxiolytic and anticonvulsant drug developed by Hoechst in the 1960s. It is used in anxiety disorders and to promote peripheral nerve healing. It does not bind to the benzodiazepine receptor though the effects are similar to that of benzodiazepines. It is more effective than lorazepam as an anxiolytic, and has fewer side effects. Etifoxine has been associated with acute liver injury.] |
|
Etidocaine
|
DB08987 |
[Etidocaine is marketed under the name Duranest. It is an injectable local anesthetic during surgery, labor, and delivery. Etidocaine has a long duration of activity, but has the main disadvantage of increased bleeding during oral surgery.] |
|
Ethoheptazine
|
DB08988 |
[Ethoheptazine is marketed under the name Zactane. It is a phenazepine based opioid analgesic. It was invented in the 1950s and is related to other drugs such as proheptazine. Ethoheptazine is no longer marketed in the United States.] |
|
PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER
|
DB07657 |
|
